It is a "long-hauler" trial. That length of a study sounds long since we are use to the quicker but depending on the disease, could go for years. Look at cancer and HIV trials for instance. Just more future catalysts if one is here in 23 months.(but measurements are in "days" so some confusion) Nice to have other things in the future pipe line.